Beauvericin counteracted multi-drug resistant Candida albicans by blocking ABC transporters

[1]  E. Brown,et al.  Antibacterial drug discovery in the resistance era , 2016, Nature.

[2]  R. Kishony,et al.  Multidrug evolutionary strategies to reverse antibiotic resistance , 2016, Science.

[3]  John J. Irwin,et al.  ZINC 15 – Ligand Discovery for Everyone , 2015, J. Chem. Inf. Model..

[4]  Jinchun Pan,et al.  Systemic Candida parapsilosis Infection Model in Immunosuppressed ICR Mice and Assessing the Antifungal Efficiency of Fluconazole , 2015, Veterinary medicine international.

[5]  Y. Tong,et al.  Synergistic combinations of antifungals and anti-virulence agents to fight against Candida albicans , 2015, Virulence.

[6]  E. Lionta,et al.  Structure-Based Virtual Screening for Drug Discovery: Principles, Applications and Recent Advances , 2014, Current topics in medicinal chemistry.

[7]  J. Imlay,et al.  Cell Death from Antibiotics Without the Involvement of Reactive Oxygen Species , 2013, Science.

[8]  Rosario Rizzuto,et al.  Mitochondria as sensors and regulators of calcium signalling , 2012, Nature Reviews Molecular Cell Biology.

[9]  D. Denning,et al.  Tackling Human Fungal Infections , 2012, Science.

[10]  Koichi Tanabe,et al.  Chimeras of Candida albicans Cdr1p and Cdr2p reveal features of pleiotropic drug resistance transporter structure and function , 2011, Molecular microbiology.

[11]  R. Prasad,et al.  Antifungal curcumin induces reactive oxygen species and triggers an early apoptosis but prevents hyphae development by targeting the global repressor TUP1 in Candida albicans. , 2010, Bioscience reports.

[12]  Y. Tong,et al.  Trichodermaketones A-D and 7-O-methylkoninginin D from the marine fungus Trichoderma koningii. , 2010, Journal of natural products.

[13]  L. Sklar,et al.  Identification of Nile red as a fluorescent substrate of the Candida albicans ATP-binding cassette transporters Cdr1p and Cdr2p and the major facilitator superfamily transporter Mdr1p. , 2009, Analytical biochemistry.

[14]  J. Collins,et al.  Role of reactive oxygen species in antibiotic action and resistance. , 2009, Current opinion in microbiology.

[15]  Yuan-Ying Jiang,et al.  Baicalein induces programmed cell death in Candida albicans. , 2009, Journal of microbiology and biotechnology.

[16]  Arthur J. Olson,et al.  AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading , 2009, J. Comput. Chem..

[17]  Lixin Zhang,et al.  An inhibition study of beauvericin on human and rat cytochrome P450 enzymes and its pharmacokinetics in rats , 2009, Journal of enzyme inhibition and medicinal chemistry.

[18]  Yue Weng,et al.  Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding , 2009, Science.

[19]  John Dunlop,et al.  hERG (KCNH2 or Kv11.1) K+ channels: screening for cardiac arrhythmia risk. , 2008, Current drug metabolism.

[20]  Yuan-Ying Jiang,et al.  RTA2, a novel gene involved in azole resistance in Candida albicans. , 2008, Biochemical and biophysical research communications.

[21]  Koichi Tanabe,et al.  ABC Transporter Cdr1p Contributes More than Cdr2p Does to Fluconazole Efflux in Fluconazole-Resistant Candida albicans Clinical Isolates , 2008, Antimicrobial Agents and Chemotherapy.

[22]  B. Priest,et al.  Role of hERG potassium channel assays in drug development , 2008, Channels.

[23]  L. Cowen,et al.  The evolution of fungal drug resistance: modulating the trajectory from genotype to phenotype , 2008, Nature Reviews Microbiology.

[24]  J. Collins,et al.  A Common Mechanism of Cellular Death Induced by Bactericidal Antibiotics , 2007, Cell.

[25]  Floyd E Romesberg,et al.  Combating bacteria and drug resistance by inhibiting mechanisms of persistence and adaptation , 2007, Nature Chemical Biology.

[26]  Y. Uehara,et al.  Characterization of Three Classes of Membrane Proteins Involved in Fungal Azole Resistance by Functional Hyperexpression in Saccharomyces cerevisiae , 2007, Eukaryotic Cell.

[27]  Jian Wang,et al.  High-throughput synergy screening identifies microbial metabolites as combination agents for the treatment of fungal infections , 2007, Proceedings of the National Academy of Sciences.

[28]  M. Pfaller,et al.  Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem , 2007, Clinical Microbiology Reviews.

[29]  R. V. Prasad,et al.  Efflux pumps in drug resistance of Candida. , 2006, Infectious disorders drug targets.

[30]  G. Jow,et al.  Induction of calcium influx from extracellular fluid by beauvericin in human leukemia cells. , 2006, Biochemical and biophysical research communications.

[31]  Torsten Schwede,et al.  BIOINFORMATICS Bioinformatics Advance Access published November 12, 2005 The SWISS-MODEL Workspace: A web-based environment for protein structure homology modelling , 2022 .

[32]  James B. Anderson.  Evolution of antifungal-drug resistance: mechanisms and pathogen fitness , 2005, Nature Reviews Microbiology.

[33]  K. Hiraga,et al.  Enniatin has a new function as an inhibitor of Pdr5p, one of the ABC transporters in Saccharomyces cerevisiae. , 2005, Biochemical and biophysical research communications.

[34]  C. Chou,et al.  Beauvericin induces cytotoxic effects in human acute lymphoblastic leukemia cells through cytochrome c release, caspase 3 activation: the causative role of calcium. , 2004, Cancer letters.

[35]  Conrad C. Huang,et al.  UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..

[36]  S. Ōmura,et al.  New beauvericins, potentiators of antifungal miconazole activity, Produced by Beauveria sp. FKI-1366. I. Taxonomy, fermentation, isolation and biological properties. , 2004, The Journal of antibiotics.

[37]  D. Sanglard,et al.  Candida albicans Mutations in the Ergosterol Biosynthetic Pathway and Resistance to Several Antifungal Agents , 2003, Antimicrobial Agents and Chemotherapy.

[38]  Manuel C. Peitsch,et al.  SWISS-MODEL: an automated protein homology-modeling server , 2003, Nucleic Acids Res..

[39]  S. Cosgrove,et al.  The impact of antimicrobial resistance on health and economic outcomes. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[40]  N Flamand,et al.  Mini mutagenicity test: a miniaturized version of the Ames test used in a prescreening assay for point mutagenesis assessment. , 2001, Toxicology in vitro : an international journal published in association with BIBRA.

[41]  F. Sharom,et al.  Linear and cyclic peptides as substrates and modulators of P-glycoprotein: peptide binding and effects on drug transport and accumulation. , 1998, The Biochemical journal.

[42]  A. Goffeau,et al.  ATPase and Multidrug Transport Activities of the Overexpressed Yeast ABC Protein Yor1p* , 1998, The Journal of Biological Chemistry.

[43]  D. Sanglard,et al.  Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterization of CDR2, a new multidrug ABC transporter gene. , 1997, Microbiology.

[44]  D. Sanglard,et al.  Susceptibilities of Candida albicans multidrug transporter mutants to various antifungal agents and other metabolic inhibitors , 1996, Antimicrobial agents and chemotherapy.

[45]  L. Reimer,et al.  Antibiotics in laboratory medicine , 1987 .

[46]  B. Ames,et al.  Methods for detecting carcinogens and mutagens with the Salmonella/mammalian-microsome mutagenicity test. , 1975, Mutation research.

[47]  Arthur J Olson,et al.  Small-molecule library screening by docking with PyRx. , 2015, Methods in molecular biology.

[48]  Clinical,et al.  Reference method for broth dilution antifungal susceptibility testing of yeasts : Approved standard , 2008 .

[49]  Y. Wang,et al.  RTA2 is involved in calcineurin-mediated azole resistance and sphingoid long-chain base release in Candida albicans , 2008, Cellular and Molecular Life Sciences.

[50]  A. Demain,et al.  Natural products : drug discovery and therapeutic medicine , 2005 .

[51]  Khyati Kapoor,et al.  Multidrug resistance in yeast Candida. , 2005, International review of cytology.

[52]  W. Delano.  The PyMOL Molecular Graphics System , 2002 .

[53]  N. Guex,et al.  SWISS‐MODEL and the Swiss‐Pdb Viewer: An environment for comparative protein modeling , 1997, Electrophoresis.

[54]  D. Sinclair,et al.  Killing by Bactericidal Antibiotics Does Not Depend on Reactive Oxygen Species , 2022 .